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Background: The identification of protein epitopes is useful for diagnostic purposes and for the development of
peptide vaccines. In this study, the epitopes of Toxoplasma gondii SAG1 were identified using synthetic peptide
techniques with the aid of bioinformatics.
Findings: Eleven peptides derived from T. gondii SAG1 were assessed by ELISA using pig sera from different time
points after infection. Four (PS4, PS6, PS10 and PS11), out of the eleven peptides tested were recognized by all sera.
Then, shorter peptides that were derived from PS4, PS6, PS10 and PS11 were predicted using bioinformatics and
tested by experimentation. Four out of nine shorter peptides were identified successfully (amino acids 106–120,
166–180, 289–300 and 313–332).
Conclusions: We have precisely located the epitopes of T. gondii SAG1 using pig sera collected at different time
points after infection. The identified epitopes may be useful for the further study of epitope-based vaccines and
diagnostic reagents.
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Toxoplasma gondii is an obligate intracellular parasite
that infects a variety of mammals and birds, causing
toxoplasmosis [1,2]. T. gondii is an important food-borne
parasite, and the primary route of transmission from ani-
mals to humans is through the consumption of infected
meat [3,4]. In some countries, pork is the most common
meat consumed, and some ethnic groups consume raw
pork; thus, pigs are considered to be the primary source of
human infection with T. gondii [5]. In addition, toxoplas-
mosis is a source of significant economic losses for swine
farmers [6]. Therefore, the development of effective diag-
nostic reagents or vaccines for controlling this infection is
required. Attempts to develop a peptide-based vaccine for
T. gondii have focused on SAG1 and shown encouraging
results [7]. Furthermore, the multiepitope antigen is one
of the most promising antigens for the serodiagnosis of
toxoplasmosis. Thus, it is very important to determine the* Correspondence: wangyh061001@163.com; zhangdl2005@163.com;
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reproduction in any medium, provided the orprecise sequences against which effective immune re-
sponses are directed. SAG1 epitopes have been studied by
different research groups [8-10]. However, it is still unclear
which SAG1 peptides are recognized by antibodies from
pigs infected with T. gondii. Therefore, B cell epitopes of
SAG1 were analyzed using a synthetic peptide technique
in combination with software-based prediction.
Serum samples
A total of 51 T. gondii-positive sera, which had been
previously collected from experimentally infected pigs by
our lab, were investigated. Twelve pig serum samples
were collected at the time of presentation of clinical
symptoms (G1); 18 follow-up specimens were taken on
days 14 to 35 after the onset of symptoms (G2), and 21
further serum samples were taken on days 60 to 120
after the onset of symptoms (G3). Toxoplasma IgM and
IgG antibodies were confirmed by T. gondii lysate
antigen-ELISA. The serum samples in G1 and G2 were
positive for IgM and IgG against T. gondii. The serum
samples in G3 were only positive for IgG against T.
gondii. Ten sera that were negative for T. gondii IgM
and IgG were used as controls. The experimental protocol
was approved by the Ethical Committee of the Lanzhoutd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Sequences of synthesized peptides
Peptides Start and end position Sequence
PS1 1–30 aa MSVSLHHFIISSGFLASMFPKAVRRAVTAG
PS2 31–60 aa VFAAPTLMSFLRCGAMASDPPLVANQVVTC
PS3 61–90 aa PDKKSTAAVILTPTENHFTLKCPKTALTEP
PS4 91–120 aa PTLAYSPNRQICPAGTTSSCTSKAVTLSSL
PS5 121–150 aa IPEAEDSWWTGDSASLDTAGIKLTVPIEKF
PS6 151–180 aa PVTTQTFVVGCIKGDDAQSCMVTVTVQARA
PS7 181–210 aa SSVVNNVARCSYGANSTLGPVKLSAEGPTT
PS8 211–240 aa MTLVCGKDGVKVPQDNNQYCSGTTLTGCNE
PS9 241–270 aa KSFKDILPKLSENPWQGNASSDNGATLTIN
PS10 271–300 aa KEAFPAESKSVIIGCTGGSPEKHHCTVQLE
PS11 301–336 aa FAGAAGSAKSSAGTASHVSIFAMVTGLIGSIAACVA
PS4-1 91–105 aa PTLAYSPNRQICPAG
PS4-2 106–120 aa TTSSCTSKAVTLSSL
PS4-3 100–114 aa QICPAGTTSSCTSKA
PS6-1 151–165 aa PVTTQTFVVGCIKGD
PS6-2 159–173 aa VGCIKGDDAQSCMVT
PS6-3 166–180 aa DAQSCMVTVTVQARA
PS10-1 271–305 aa KEAFPAESKSVIIGC
PS10-2 281–294 aa VIIGCTGGSPEKHH
PS10-3 289–300 aa SPEKHHCTVQLE
PS11-1 301–315 aa FAGAAGSAKSSAGTA
PS11-2 313–332 aa GTASHVSIFAMVTGLIGSIA
PS11-3 306–320 aa GSAKSSAGTASHVSI
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Synthetic peptides
Based on the sequence of T. gondii SAG1 (Genbank
Accession No. FJ455529), 20 non-overlapping or over-
lapping 12–36 mer peptides were synthesized by GL
Biochem Ltd (Shanghai, China). Peptide sequences are
shown in Table 1.
ELISA analysis
ELISA for each peptide were performed as described by
Cardona et al. [10], except that microplates were coated
with 10 μg/ml peptide and peroxidase-conjugated anti-pig
IgG (1:4000) was used as the secondary antibody. PS1 was
negative to all sera; PS2, PS3, PS5, PS7, PS8 and PS9 were
recognized by few or partial sera (PS2: 5/51, PS3: 13/51,
PS5: 24/51, PS7: 32/51, PS8: 6/51 and PS9: 25/51), and only
Four peptides (PS4, PS6, PS10 and PS11) were recognized
by all sera (Figure 1). For each of the 4 peptides, no
significant differences were observed between the mean
absorbances of the three groups, as determined by an
ANOVA statistical test. The mean absorbance ± standard
deviation of one peptide (amino acids 271–300) wassignificantly higher (0.337 ± 0.053) than that of the other
peptides (PS4: 0.235 ± 0.025, p = 0.000; PS6: 0.237 ± 0.0028,
p = 0.000; PS11: 0.266 ± 0.039, p = 0.001). Five peptides
(amino acids 61–80, 181–200, 241–260 and 301–320)
derived from SAG1 were determined to be B cell epitopes,
and one peptide (amino acids 301–320) was the peptide
that was most strongly recognized by sera from patients
with human ocular toxoplasmosis [10]. A robust immuno-
logical response to the SAG1 is associated with chronic
Toxoplasma infection in humans [11]. However, we found
that peptides derived from SAG1 were capable of being
recognized by pig sera from different time points after
infection, which is different from previous reports. The
discrepancy could be explained by differences in parasite
strains, by using different animal models as well as by the
different MHC-types between human and pig.
Precise definition of the epitopes
To further determine the epitopes of SAG1 and decrease
the number of laboratory experiments, bioinformatics
was used to predict the epitopes. The secondary structure
and the surface properties of the SAG1 were analyzed as
described by Zhang [12]. The results are shown in Figure 2.
Based on these results, 9 shorter peptides that were derived
Figure 1 ELISA of IgG antibodies against different peptides in four groups of pig sera. (A), (B), (C) and (D) show the absorbances targeting
to PS4, PS6, PS10 and PS11, respectively. The cut-off point for the assay is indicated by the horizontal line.
Figure 2 Secondary structures, flexibility, hydrophilicity, surface probability and antigenicity index for T. gongdii SAG1.
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Figure 3 ELISA of IgG antibodies against different peptides in four groups of pig sera. (A), (B), (C) and (D) show the absorbances targeting
to PS4-2, PS6-3, PS10-3 and PS11-2, respectively. The cut-off point for the assay is indicated by the horizontal line.
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investigation (Table 1). These peptides were tested using
pig sera as described above. Four out of 9 peptides
(PS4-2, PS6-3, PS10-3 and PS11-2) were recognized by
all sera. The results are shown in Figure 3.
Conclusion
Conformational epitope selection needs to determine the
tertiary structure of antigen in order to identify antibody
interacting residues in antigen. Experimental techniques
such as crystallography are expensive and time consuming.
Thus, our work focuses on linear epitope selection. In this
study, we have located the epitopes of T. gondii SAG1 to ashorter sequence than had been identified previously. The
identified epitopes will be useful in vaccine and diagnostic
reagent design.
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